Stocks News

LAST PRICE
21.6200
TODAY'S CHANGE (%)
Trending Down-0.0900 (-0.4146%)

Bid / Lots
21.6800/ 4
Ask / Lots
21.9900/ 1
Open / Previous Close
21.8700 / 21.7100
Day Range
Low 21.5900
High 21.9500
52 Week Range
Low 16.0150
High 23.2600
Volume
4,223,607
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 18, 2024
- Healthpeak Properties Boosts Outlook for 2024 Adjusted FFO, from 4:46PM ET on Monday Nov 18, 2024 by MT Newswires
  4:46PM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: DOC
  04:46 PM EST, 11/18/2024 (MT Newswires) -- Healthpeak Properties (DOC) late Monday nudged its forecast for 2024 adjusted funds from operations slightly higher to reflect the continued strong performance of its portfolio of outpatient medical, labora...
- Press Release: Healthpeak Properties Raises 2024 Guidance, from 4:15PM ET on Monday Nov 18, 2024 by Dow Jones
  4:15PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: DOC
- Healthpeak Properties Raises 2024 Guidance, from 4:15PM ET on Monday Nov 18, 2024 by Dow Jones
  4:15PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: DOC
  
  Healthpeak Properties Raises 2024 Guidance
  DENVER--(BUSINESS WIRE)--November 18, 2024--
  Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced it increased full year 2024 guidance, driven by the continued strong performance of its high-quality lab, outpatient medical, and CCRC portfolios. Healthpeak's updated guidance ranges include:
Nov 12, 2024
- Citigroup Adjusts Price Target on Healthpeak Properties to $23 From $22, Maintains Neutral Rating, from 6:32AM ET on Tuesday Nov 12, 2024 by MT Newswires
  6:32AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: DOC
  06:32 AM EST, 11/12/2024 (MT Newswires) -- Healthpeak Properties (DOC) has an average outperform rating and a price target range of $23 to $30.50, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resear...
Nov 11, 2024
- BMO Capital Adjusts Price Target on Healthpeak Properties to $25.50 From $26, Maintains Outperform, from 7:07AM ET on Monday Nov 11, 2024 by MT Newswires
  7:07AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: DOC
  07:07 AM EST, 11/11/2024 (MT Newswires) -- Healthpeak Properties (DOC) has an average outperform rating and a price target range of $22 to $30.50, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resear...

Today
- Leerink Adjusts Price Target on Quest Diagnostics to $169 From $165, Maintains Market Perform Rating, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: DGX
Yesterday
- Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM, from 5:31PM ET on Thursday Nov 21, 2024 by Dow Jones
  5:31PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: NTRA
Nov 19, 2024
- UBS Adjusts Price Target on Natera to $209 From $145, Maintains Buy Rating, from 11:00AM ET on Tuesday Nov 19, 2024 by MT Newswires
  11:00AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: NTRA
Nov 18, 2024
- DJ Natera Is Maintained at Overweight by Piper Sandler, from 12:34PM ET on Monday Nov 18, 2024 by Dow Jones
  12:34PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: NTRA
Nov 14, 2024
- DJ Natera Is Maintained at Overweight by Morgan Stanley, from 11:45AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:45AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: NTRA
Nov 13, 2024
- DJ Natera Is Maintained at Buy by TD Cowen, from 1:27PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:27PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NTRA
- --Morgan Stanley Adjusts Natera Price Target to $176 From $132, Maintains Overweight Rating, from 12:47PM ET on Wednesday Nov 13, 2024 by MT Newswires
  12:47PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: NTRA
- DJ Natera Is Maintained at Buy by Craig-Hallum, from 11:38AM ET on Wednesday Nov 13, 2024 by Dow Jones
  11:38AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NTRA
- DJ Natera Up Nearly 23%, on Track for Record High Close -- Data Talk, from 11:36AM ET on Wednesday Nov 13, 2024 by Dow Jones
  11:36AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NTRA
- DJ Natera Is Maintained at Overweight by JP Morgan, from 10:21AM ET on Wednesday Nov 13, 2024 by Dow Jones
  10:21AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: NTRA

Healthpeak Properties Inc
NYSE:DOCUnited States

Search Criteria

Nov 18, 2024

Healthpeak Properties Boosts Outlook for 2024 Adjusted FFO, from 4:46PM ET on Monday Nov 18, 2024 by MT Newswires

Press Release: Healthpeak Properties Raises 2024 Guidance, from 4:15PM ET on Monday Nov 18, 2024 by Dow Jones

Healthpeak Properties Raises 2024 Guidance, from 4:15PM ET on Monday Nov 18, 2024 by Dow Jones

Nov 12, 2024

Citigroup Adjusts Price Target on Healthpeak Properties to $23 From $22, Maintains Neutral Rating, from 6:32AM ET on Tuesday Nov 12, 2024 by MT Newswires

Nov 11, 2024

BMO Capital Adjusts Price Target on Healthpeak Properties to $25.50 From $26, Maintains Outperform, from 7:07AM ET on Monday Nov 11, 2024 by MT Newswires

Peers Headlines

Today

Leerink Adjusts Price Target on Quest Diagnostics to $169 From $165, Maintains Market Perform Rating, from 9 hours ago by MT Newswires

Yesterday

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM, from 5:31PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 19, 2024

UBS Adjusts Price Target on Natera to $209 From $145, Maintains Buy Rating, from 11:00AM ET on Tuesday Nov 19, 2024 by MT Newswires

Nov 18, 2024

DJ Natera Is Maintained at Overweight by Piper Sandler, from 12:34PM ET on Monday Nov 18, 2024 by Dow Jones

Nov 14, 2024

DJ Natera Is Maintained at Overweight by Morgan Stanley, from 11:45AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

DJ Natera Is Maintained at Buy by TD Cowen, from 1:27PM ET on Wednesday Nov 13, 2024 by Dow Jones

--Morgan Stanley Adjusts Natera Price Target to $176 From $132, Maintains Overweight Rating, from 12:47PM ET on Wednesday Nov 13, 2024 by MT Newswires

DJ Natera Is Maintained at Buy by Craig-Hallum, from 11:38AM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Natera Up Nearly 23%, on Track for Record High Close -- Data Talk, from 11:36AM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Natera Is Maintained at Overweight by JP Morgan, from 10:21AM ET on Wednesday Nov 13, 2024 by Dow Jones